Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study

NCT05202015 · clinicaltrials.gov ↗

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

HCC
Hepatocellular Carcinoma
MRI

Interventions

DRUG: MRI using a hepatobiliary phase contrast agent (Gd-EOB-DPTA)

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]